FCM
APTO

Firestone Capital Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Firestone Capital Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22
Closed -$59K – 464
2020
Q1 		$59K Hold
22
– – 0.03% 168
2019
Q4 		$57K Buy
+22
New +$28.7K 0.02% 195

Other funds holding APTO

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Firestone Capital Management's APTO Position: Q2 2020 in Review

Firestone Capital Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2020, closing a stake of 22 shares — an estimated $59K sold.

Firestone Capital Management first reported a position in APTO in Q4 2019 and held it in 2 quarters. The position peaked at $59K in Q1 2020. 58 funds tracked by Wall St. Rank hold APTO as of Q2 2020.

  • Firestone Capital Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Firestone Capital Management sold 22 Aptose Biosciences, Inc. shares in Q2 2020, an estimated $59K.
  • Firestone Capital Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 2 quarters.
  • Firestone Capital Management's Aptose Biosciences, Inc. position peaked at $59K in Q1 2020.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2020.

Based on Firestone Capital Management's 13F filing for Q2 2020, filed 27 Jul 2020.